Clinical Trials Browser

Interventional × efgartigimod alfa × 1 year × Clear all

NCT07217587 2026-03-13

EPIC

Phase 3 Recruiting

Myasthenia Gravis

NCT07072988 2025-09-24

OPTIMAGE

Phase 4 Recruiting

Myasthenia Gravis

NCT06765161 2025-07-29

Efgartigimod in IVIG Dependent Myasthenia Gravis Patients

Phase 3 Recruiting

Myasthenia Gravis